Loading...

Mainz Biomed B.V.

MYNZNASDAQ
Healthcare
Medical - Diagnostics & Research
$1.72
$-0.03(-1.71%)

Mainz Biomed B.V. (MYNZ) Stock Competitors & Peer Comparison

See (MYNZ) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Diagnostics & Research Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
MYNZ$1.72-1.71%7.9M-0.08-$22.36N/A
DHR-PB$1,261.26-0.78%916.8B146.01$8.64+0.56%
TMO$490.75-1.85%185.2B28.36$17.30+0.33%
DHR$207.73-1.92%148.8B44.20$4.70+0.56%
IDXX$641.35-0.65%51.3B53.40$12.01N/A
A$119.15-2.04%33.8B29.33$4.06+0.81%
IQV$188.02-1.64%32B27.25$6.90N/A
MTD$1,289.78-2.40%26.6B32.76$39.38N/A
NTRA$162.47-1.89%22.3B-85.51-$1.90N/A
DGX$178.66-0.87%20B21.42$8.34+1.72%
Showing 1 to 10 of 89 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

MYNZ vs DHR-PB Comparison August 2025

MYNZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MYNZ stands at 7.9M. In comparison, DHR-PB has a market cap of 916.8B. Regarding current trading prices, MYNZ is priced at $1.72, while DHR-PB trades at $1,261.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MYNZ currently has a P/E ratio of -0.08, whereas DHR-PB's P/E ratio is 146.01. In terms of profitability, MYNZ's ROE is -22.70%, compared to DHR-PB's ROE of +0.07%. Regarding short-term risk, MYNZ is more volatile compared to DHR-PB. This indicates potentially higher risk in terms of short-term price fluctuations for MYNZ.Check DHR-PB's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions

;